71 related articles for article (PubMed ID: 19408311)
1. Identification and characterization of a novel CXC chemokine in xenograft tumor induced by mas-overexpressing cells.
Lin WZ; Li ZF; Tsang SY; Lung LK; Wang DK; Chan WY; Zhu YK; Lee SS; Cheung WT
Int J Cancer; 2009 Sep; 125(6):1316-27. PubMed ID: 19408311
[TBL] [Abstract][Full Text] [Related]
2. Molecular and functional characterization of tumor-induced factor (TIF): Hamster homolog of CXCL3 (GRO
Jin L; Li ZF; Wang DK; Sun M; Qi W; Ma Q; Zhang L; Chu C; Chan EYM; Lee SST; Wise H; To KF; Shi Y; Zhou N; Cheung WT
Cytokine; 2018 Feb; 102():62-75. PubMed ID: 29276973
[TBL] [Abstract][Full Text] [Related]
3. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of surrogate peptide ligand for orphan G protein-coupled receptor mas using phage-displayed peptide library.
Bikkavilli RK; Tsang SY; Tang WM; Sun JX; Ngai SM; Lee SS; Ko WH; Wise H; Cheung WT
Biochem Pharmacol; 2006 Jan; 71(3):319-37. PubMed ID: 16336942
[TBL] [Abstract][Full Text] [Related]
5. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
Nagpal ML; Chen Y; Lin T
J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
[TBL] [Abstract][Full Text] [Related]
6. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
[TBL] [Abstract][Full Text] [Related]
7. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
8. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
Wen Y; Giardina SF; Hamming D; Greenman J; Zachariah E; Bacolod MD; Liu H; Shia J; Amenta PS; Barany F; Paty P; Gerald W; Notterman D
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5951-9. PubMed ID: 17062666
[TBL] [Abstract][Full Text] [Related]
9. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
11. [Transforming effect of PDGFRA gene mutant on the cell function in gastrointestinal stromal tumor].
Yang L; Bai CG; Hou XW; Liu XH; Ma DL
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):500-4. PubMed ID: 19950696
[TBL] [Abstract][Full Text] [Related]
12. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
[TBL] [Abstract][Full Text] [Related]
13. Expression and effect of CXCL14 in colorectal carcinoma.
Lin K; Zou R; Lin F; Zheng S; Shen X; Xue X
Mol Med Rep; 2014 Sep; 10(3):1561-8. PubMed ID: 24938992
[TBL] [Abstract][Full Text] [Related]
14. Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice.
Ho DH; Vu H; Brown SA; Donohue PJ; Hanscom HN; Winkles JA
Cancer Res; 2004 Dec; 64(24):8968-72. PubMed ID: 15604260
[TBL] [Abstract][Full Text] [Related]
15. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA
Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280
[TBL] [Abstract][Full Text] [Related]
16. CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury.
Vanderbilt JN; Mager EM; Allen L; Sawa T; Wiener-Kronish J; Gonzalez R; Dobbs LG
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):661-8. PubMed ID: 12829448
[TBL] [Abstract][Full Text] [Related]
17. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
[TBL] [Abstract][Full Text] [Related]
18. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
[TBL] [Abstract][Full Text] [Related]
19. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
20. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
Dos Santos C; Karaky R; Renoir D; Hamma-Kourbali Y; Albanese P; Gobbo E; Griscelli F; Opolon P; Dalle S; Perricaudet M; Courty J; Delbé J
Int J Cancer; 2010 Sep; 127(5):1038-51. PubMed ID: 20013808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]